Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Unit price / market price
-
$0.9908
-
Total 13F principal
-
$446,064,779
-
Principal change
-
-$16,421
-
Total reported value
-
$443,342,534
-
Number of holders
-
48
-
Value change
-
+$475,537
-
Number of buys
-
23
-
Number of sells
-
15
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2023
As of 30 Sep 2023 BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 had 48 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $446,064,779 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Voya Investment Management LLC, MACKAY SHIELDS LLC, LAZARD ASSET MANAGEMENT LLC, Wellesley Asset Management, ADVENT CAPITAL MANAGEMENT /DE/, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, Thrivent Financial for Lutherans, and Sonora Investment Management Group, LLC.
This table shows 48 bond principal holders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.